Ministry of Chemicals and Fertilizers notifies ceiling price of certain scheduled formulations

Through an order dated 20th September, 2017 issued under the Drugs (Prices Control) Order, 2013 (“DPCO, 2013”), the Ministry of Chemicals and Fertilizers (“Ministry”) has fixed and notified the ceiling prices, (exclusive of Goods and Services Tax) of scheduled formulations specified below:


Sl. No. Name of the Scheduled Formulation Dosage form & Strength Unit Ceiling Price


Rifabutin Capsule 150mg 1 Capsule 35.99
Fluconazole Oral Liquid 50mg/5ml 1 ML 2.28
Sumatriptan Tablet 25mg 1 Tablet 30.21
Sumatriptan Tablet 50mg 1 Tablet 46.76
Iohexol Injection 300mg iodine/ml 1 ML 15.08
Hepatitis B immunoglobulin   Each Pack 4998.20
Isoniazid Tablet 300mg 1 Tablet 1.08
Isoniazid Tablet 100mg 1 Tablet 0.62
Actinomycin D Powder for Injection 0.5mg Each Pack 287.76
Ifosfamide Powder for Injection 1g Each Pack 328.33
Vinblastine Injection 1mg/ml 1 ML 18.62
Silver Sulphadiazine Cream 1% 1 GM 0.27
Measles vaccine Vaccine Each Pack (0.5ml) 46.27
Cloxacillin Powder for Injection250mg Each Pack 4.03
Griseofulvin Tablet 125mg 1 Tablet 0.74
Diloxanide furoate Tablet 500mg 1 Tablet 0.96
Glycerin Oral Liquid 1 ML 0.13599
Chlorhexidine Solution 5% (Concentrate for dilution) 1 ML 0.14194
Hydrogen peroxide Solution 6% 1 ML 0.03634
Mannitol Injection 10% 1 ML 0.14626
Dicyclomine Tablet 10mg 1 Tablet 0.09955
Anti-tetanus immunoglobulin   Each Pack 748.06
Diphtheria antitoxin 10000 IU Each Pack 1189.22
Pyridoxine Tablet 10mg 1 Tablet 0.10491
Vitamin A Capsule 50000 IU 1 Capsule 0.50
Ascorbic Acid (Vitamin C) Tablet 100mg 1 Tablet 0.17603
Artesunate (A) + Sulphadoxine – Pyrimethamine (B) Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B) Combi pack 26.77
Artesunate (A) + Sulphadoxine – Pyrimethamine (B) Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B) Combi pack 36.34
Artesunate (A) + Sulphadoxine – Pyrimethamine (B) Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B) Combi pack 33.13
Artesunate (A) + Sulphadoxine – Pyrimethamine (B) Tablet 25 mg (A) + 1 Tablet (250 mg + 12.5 mg) (B) Combi pack 17.84
Acetylsalicylic acid Tablet 350mg 1 Tablet 0.28
Ferrous salt (A) + Folic acid (B) Oral liqiud 20mg elemental iron (A) + 100mcg (B)/ml 1 ML 0.12074
Ferrous salt (A) + Folic acid (B) Tablet 100 mg elemental iron (A) + 500 mcg (B) 1 Tablet 0.09821
Ferrous salt (A) + Folic acid (B) Tablet 45mg elemental iron (A) + 400 mcg (B) 1 Tablet 0.12755
White Petrolatum Jelly 100% 1 GM 0.0843
Dicyclomine Oral Solution 10mg/5ml 1 ML 0.15089
Vitamin A Oral liquid 100000 IU/ml 1 ML 0.47
Rabies Human Monoclonal Antibody (rDNA) (Rabishield) Rabies Human Monoclonal Antibody 100IU/2.5ml

Each ml contains: Rabies Human Monoclonal Antibody (rDNA) 40IU

Each Pack 8,055.68
Rabies Human Monoclonal Antibody (rDNA) (Rabishield) Rabies Human Monoclonal Antibody 250IU/2.5ml

Each ml contains: Rabies Human Monoclonal Antibody (rDNA) 100IU

Each Pack 20,139.20


Key Features:

  • All manufacturers of scheduled formulations, selling branded or generic or both versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, have been mandated to revise the prices of all such formulations downward not exceeding the ceiling price as specified in the Column “Ceiling Price” in the table above.


  • All the existing manufacturers of above mentioned scheduled formulations, having MRP lower than the ceiling price specified in column “Ceiling Price” in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with DPCO, 2013.


  • After notification of the ceiling price, the manufacturer must issue a price list in Form–V to the National Pharmaceutical Pricing Authority (“NPPA”) through Integrated Pharmaceutical Database Management System (“IPDMS”) Portal and submit a copy to State Drug Controller and dealers.


  • Every retailer and dealer must display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business so that it is easily accessible to any person wishing to consult the same.


  • The manufacturers of the above mentioned scheduled formulations must furnish quarterly return to the NPPA through the IPDMS Portal for production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013.


  • The manufacturers not complying with the ceiling price specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO, 2013 read with Essential Commodities Act, 1955.



Source: Ministry of Chemicals and Fertilizers

Share this: